Literature DB >> 7911396

c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties.

D Yu1, S S Wang, K M Dulski, C M Tsai, G L Nicolson, M C Hung.   

Abstract

Previously, we and others have reported high levels of expression of the c-erbB-2/neu gene in non-small cell lung cancer cell lines and primary tumors. We have also found that expression of c-erbB-2/neu-encoded p185neu was correlated with lymph node metastasis in lung squamous cell carcinomas. To investigate the potential role of the c-erbB-2/neu gene in lung cancer metastasis systematically, we introduced the human c-erbB-2/neu gene into very low p185neu-expressing NCI-H460 human non-small cell lung cancer cells and then examined the experimental metastatic potentials among the parental NCI-H460 cells and stable transfectants with increased expression of p185neu. Compared with the parental NCI-H460 cells, the NCI-H460 transfectants overexpressing p185neu produced significantly more pulmonary and extrapulmonary metastatic tumors in nude mice. The changes in experimental metastatic potential in vivo were accompanied by increased invasiveness in vitro. In addition, important steps in the invasion and metastasis process, such as secretion of basement membrane-degradative enzymes and migration through reconstituted basement membrane (Matrigel), were also increased in the NCI-H460 transfectants overexpressing p185neu. Moreover, scanning electron microscopy revealed that the p185neu-overexpressing NCI-H460 transfectants had significantly more microvilli and membrane protrusions than the parental cells, correlating with the increased invasive properties of these cells. The results demonstrate that overexpression of p185neu can enhance the experimental metastatic potential of NCI-H460 human lung cancer cells by promoting invasion and the other steps in the metastatic cascade.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911396

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

Review 1.  ErbB receptors and EGF-like ligands: cell lineage determination and oncogenesis through combinatorial signaling.

Authors:  R Pinkas-Kramarski; I Alroy; Y Yarden
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

2.  Plasma gelatinase levels in patients with primary breast cancer in relation to axillary lymph node status, Her2/neu expression and other clinicopathological variables.

Authors:  J Decock; W Hendrickx; H Wildiers; M R Christiaens; P Neven; M Drijkoningen; R Paridaens
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  Heregulin-beta promotes matrix metalloproteinase-7 expression via HER2-mediated AP-1 activation in MCF-7 cells.

Authors:  Guogang Yuan; Lu Qian; Lun Song; Ming Shi; Dan Li; Ming Yu; Meiru Hu; Beifen Shen; Ning Guo
Journal:  Mol Cell Biochem       Date:  2008-07-04       Impact factor: 3.396

Review 4.  New prognostic factors in resectable non-small cell lung cancer.

Authors:  E F Smit; H J Groen; T A Splinter; T Ebels; P E Postmus
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

Review 5.  Molecular analysis of premalignant and carcinoma in situ lesions of the human breast.

Authors:  P S Steeg; S E Clare; J A Lawrence; Q Zhou
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

6.  Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma.

Authors:  G Sehgal; J Hua; E J Bernhard; I Sehgal; T C Thompson; R J Muschel
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

7.  C-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cells.

Authors:  S Lin; D Rusciano; P Lorenzoni; G Hartmann; W Birchmeier; S Giordano; P Comoglio; M M Burger
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

8.  Expression and association of HER2 with prognosis in early-stage (T1-T2N0M0) non-small cell lung cancer.

Authors:  Qing Xia; Zhihua Zhu; Jian Wang; Dongrong Situ; Ningning Zhou; Wenqi Jang
Journal:  Tumour Biol       Date:  2012-06-27

Review 9.  Lung cancer. 9: Molecular biology of lung cancer: clinical implications.

Authors:  K M Fong; Y Sekido; A F Gazdar; J D Minna
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

10.  Characteristic gene expression profiles in the progression from liver cirrhosis to carcinoma induced by diethylnitrosamine in a rat model.

Authors:  Yue-Fang Liu; Bin-Shan Zha; Hui-Lin Zhang; Xiao-Jing Zhu; Yu-Hua Li; Jin Zhu; Xiao-Hong Guan; Zhen-Qing Feng; Jian-Ping Zhang
Journal:  J Exp Clin Cancer Res       Date:  2009-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.